Company · CIK 1835205
IBERE PHARMACEUTICALS
Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26
| CIK | 1835205 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 6770 — Blank Checks |
| Incorporated in | E9 |
| Business address | PA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-07-16 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-252863 | 2021-02-09 | 2021-03-01 | 4 |
Filings
5| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2021-03-01 | 424B4Final prospectus | 333-252863 | 0001104659-21-029859 |
| 2021-02-25 | EFFECTDeclared effective | 333-252863 | 9999999995-21-000745 |
| 2021-02-22 | S-1/AAmendment | 333-252863 | 0001104659-21-026147 |
| 2021-02-09 | S-1Registration filed | 333-252863 | 0001104659-21-015548 |
| 2020-12-07 | DRSDraft made public | 377-03858 | 0001104659-20-132899 |